Skip to content

Effects Oral Agents Vitamine D On COPD

Evaluation of Effects Oral Supplements Vitamine D on COPD Exacerbation and FEV1 in Patients With Severe and Very Severe COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012071810332N1
Enrollment
88
Registered
2012-08-07
Start date
2012-03-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Severe and very severe COPD. Condition 2: Added at 2012-08-07: chronic obstructive pulmonary diseases. Chronic obstructive pulmonary diseases Added at 2012-08-07:

Interventions

Intervention 1: patients in case group have intervened with oral agents vitamineD(in 6 months with doses100000internationalunits of vitamin D3 monthly within 6months)and routin drugthrapy for Chronic
Prevention
Treatment - Drugs
patients in case group have intervened with oral agents vitamineD(in 6 months with doses100000internationalunits of vitamin D3 monthly within 6months)and routin drugthrapy for Chronic obstructive pulm
in control group have treatment with routine drugs for Chronic obstructive pulmonary diseases

Sponsors

Khorramabad Univercity Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusioncriteria:COPD patients with FEV1/FVC<0/7 and FEV1<50%;negative past medical history of vitamines D disorders exclusion criteria:positive past medical history of vitamine D disorders

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
FEV1. Timepoint: Before intervention and after intervention. Method of measurement: Spirometery(PFT).

Secondary

MeasureTime frame
COPD Exacerbation. Timepoint: Before and mean and afterof intervention. Method of measurement: Physical exam.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDoktor Abolphazl Zendedel

Khorramabad Univercity Of Medical Sciences

www.a.zendedel@yahoo.com+98 66 1620 0133

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026